gal 9 Search Results


93
MedChemExpress gal 9
FIGURE 6 | Effects of exogenous Galectin‐9 intervention and/or CD137 overexpression on the CT26 tumor model. (A) Collective photograph of the mice at the end of the experiment. (B) Collective photograph of the completely excised tumor tissues from each group of mice. (C) Growth curves of tumors in each group of mice. (D) Trends in body weight changes for each group of mice. (E) Representative images of the distribution of Ki67 immunohistochemical staining in the tumor tissues of each group. (F) Comparative analysis of the proportion of Ki67 positive cells in the tumor tissues of each group. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle or <t>Gal‐9,</t> #p < 0.05 versus CD137‐OE. SD, standard deviation.
Gal 9, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gal 9/product/MedChemExpress
Average 93 stars, based on 1 article reviews
gal 9 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Miltenyi Biotec gal 9 protein
FIGURE 6 | Effects of exogenous Galectin‐9 intervention and/or CD137 overexpression on the CT26 tumor model. (A) Collective photograph of the mice at the end of the experiment. (B) Collective photograph of the completely excised tumor tissues from each group of mice. (C) Growth curves of tumors in each group of mice. (D) Trends in body weight changes for each group of mice. (E) Representative images of the distribution of Ki67 immunohistochemical staining in the tumor tissues of each group. (F) Comparative analysis of the proportion of Ki67 positive cells in the tumor tissues of each group. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle or <t>Gal‐9,</t> #p < 0.05 versus CD137‐OE. SD, standard deviation.
Gal 9 Protein, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gal 9 protein/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
gal 9 protein - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Proteintech anti lgals9
FIGURE 6 | Effects of exogenous Galectin‐9 intervention and/or CD137 overexpression on the CT26 tumor model. (A) Collective photograph of the mice at the end of the experiment. (B) Collective photograph of the completely excised tumor tissues from each group of mice. (C) Growth curves of tumors in each group of mice. (D) Trends in body weight changes for each group of mice. (E) Representative images of the distribution of Ki67 immunohistochemical staining in the tumor tissues of each group. (F) Comparative analysis of the proportion of Ki67 positive cells in the tumor tissues of each group. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle or <t>Gal‐9,</t> #p < 0.05 versus CD137‐OE. SD, standard deviation.
Anti Lgals9, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti lgals9/product/Proteintech
Average 93 stars, based on 1 article reviews
anti lgals9 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

92
Miltenyi Biotec rea435
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Rea435, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rea435/product/Miltenyi Biotec
Average 92 stars, based on 1 article reviews
rea435 - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

93
Proteintech 17938 1 ap
Immunophenotyping panel for multiplexed tissue imaging of cancer.
17938 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/17938 1 ap/product/Proteintech
Average 93 stars, based on 1 article reviews
17938 1 ap - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Addgene inc pjjiadest apex2 gal9
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Pjjiadest Apex2 Gal9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pjjiadest apex2 gal9/product/Addgene inc
Average 93 stars, based on 1 article reviews
pjjiadest apex2 gal9 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

92
Elabscience Biotechnology gal 9 elisa kits
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Gal 9 Elisa Kits, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gal 9 elisa kits/product/Elabscience Biotechnology
Average 92 stars, based on 1 article reviews
gal 9 elisa kits - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

90
Boster Bio immunosorbent assay
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Immunosorbent Assay, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunosorbent assay/product/Boster Bio
Average 90 stars, based on 1 article reviews
immunosorbent assay - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
MBL Life science anti-gal-9 monoclonal antibody eca8
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Anti Gal 9 Monoclonal Antibody Eca8, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-gal-9 monoclonal antibody eca8/product/MBL Life science
Average 90 stars, based on 1 article reviews
anti-gal-9 monoclonal antibody eca8 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Promega pcmv-gal-9 3'utr-mu
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Pcmv Gal 9 3'utr Mu, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcmv-gal-9 3'utr-mu/product/Promega
Average 90 stars, based on 1 article reviews
pcmv-gal-9 3'utr-mu - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
MBL Life science antihuman gal9 mab
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Antihuman Gal9 Mab, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antihuman gal9 mab/product/MBL Life science
Average 90 stars, based on 1 article reviews
antihuman gal9 mab - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BlueGene Biotech human gal-9 elisa
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Human Gal 9 Elisa, supplied by BlueGene Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gal-9 elisa/product/BlueGene Biotech
Average 90 stars, based on 1 article reviews
human gal-9 elisa - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


FIGURE 6 | Effects of exogenous Galectin‐9 intervention and/or CD137 overexpression on the CT26 tumor model. (A) Collective photograph of the mice at the end of the experiment. (B) Collective photograph of the completely excised tumor tissues from each group of mice. (C) Growth curves of tumors in each group of mice. (D) Trends in body weight changes for each group of mice. (E) Representative images of the distribution of Ki67 immunohistochemical staining in the tumor tissues of each group. (F) Comparative analysis of the proportion of Ki67 positive cells in the tumor tissues of each group. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle or Gal‐9, #p < 0.05 versus CD137‐OE. SD, standard deviation.

Journal: Molecular carcinogenesis

Article Title: CD137 Protein Expression Pattern Determines the Functional Role of Galectin-9 in Colorectal Cancer.

doi: 10.1002/mc.23838

Figure Lengend Snippet: FIGURE 6 | Effects of exogenous Galectin‐9 intervention and/or CD137 overexpression on the CT26 tumor model. (A) Collective photograph of the mice at the end of the experiment. (B) Collective photograph of the completely excised tumor tissues from each group of mice. (C) Growth curves of tumors in each group of mice. (D) Trends in body weight changes for each group of mice. (E) Representative images of the distribution of Ki67 immunohistochemical staining in the tumor tissues of each group. (F) Comparative analysis of the proportion of Ki67 positive cells in the tumor tissues of each group. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle or Gal‐9, #p < 0.05 versus CD137‐OE. SD, standard deviation.

Article Snippet: The mice were divided into the following experimental groups: Gal‐9 Group: Mice were given a daily intravenous injection of 30 μg/mouse of Gal‐9 (MedChemExpress, Monmouth Junction, NJ, USA) [22] after tumor cell inoculation.

Techniques: Over Expression, Immunohistochemical staining, Staining, Standard Deviation

FIGURE 7 | Effects of Galectin‐9 supplementation and CD137 knockout/overexpression on the MC38 tumor model. (A) Collective photograph of the mice at the end of the experiment. (B) Collective photograph of the completely excised tumor tissues from each group of mice. (C) Growth curves of tumors in each group of mice. (D) Trends in body weight changes for each group of mice. (E) Representative images of the distribution of Ki67 immunohistochemical staining in the tumor tissues of each group. (F) Comparative analysis of the proportion of Ki67 positive cells in the tumor tissues of each group. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle, #p < 0.05 versus Gal‐9, &p < 0.05 versus CD137‐OE, ▲p < 0.05 versus Tnfrsf9‐KO. SD, standard deviation.

Journal: Molecular carcinogenesis

Article Title: CD137 Protein Expression Pattern Determines the Functional Role of Galectin-9 in Colorectal Cancer.

doi: 10.1002/mc.23838

Figure Lengend Snippet: FIGURE 7 | Effects of Galectin‐9 supplementation and CD137 knockout/overexpression on the MC38 tumor model. (A) Collective photograph of the mice at the end of the experiment. (B) Collective photograph of the completely excised tumor tissues from each group of mice. (C) Growth curves of tumors in each group of mice. (D) Trends in body weight changes for each group of mice. (E) Representative images of the distribution of Ki67 immunohistochemical staining in the tumor tissues of each group. (F) Comparative analysis of the proportion of Ki67 positive cells in the tumor tissues of each group. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle, #p < 0.05 versus Gal‐9, &p < 0.05 versus CD137‐OE, ▲p < 0.05 versus Tnfrsf9‐KO. SD, standard deviation.

Article Snippet: The mice were divided into the following experimental groups: Gal‐9 Group: Mice were given a daily intravenous injection of 30 μg/mouse of Gal‐9 (MedChemExpress, Monmouth Junction, NJ, USA) [22] after tumor cell inoculation.

Techniques: Knock-Out, Over Expression, Immunohistochemical staining, Staining, Standard Deviation

FIGURE 8 | Investigating the impacts of Galectin‐9 supplementation and CD137 knockout/overexpression on the infiltration of immune cells on the tumor microenvironment of murine colon cancer. (A) Representative images of CD137 expression distribution in CT26 and MC38 colon cancer tumor tissues, demonstrated through immunohistochemical staining. (B) Comparative analysis of the proportion of CD137‐positive cells in CT26 and MC38 colon cancer tumor tissues. (C) Distribution of activated T cells in CT26 colon cancer tumor tissues, shown using CD3 and CD137 dual immunofluorescence labeling. (D, E) Comparative analysis of the proportion of CD3+ cells and CD3+CD137+ positive cells in CT26 colon cancer tumor tissues. (F) Similarly, using CD3 and CD137 dual immunofluorescence labeling, the distribution of activated T cells in MC38 colon cancer tumor tissues are shown. (G, H) Comparative analysis of the proportion of CD3+ and CD3+CD137+ positive cells in MC38 colon cancer tumor tissues. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle, #p < 0.05 versus Gal‐9, &p < 0.05 versus CD137‐OE, ▲p < 0.05 versus Tnfrsf9‐KO. SD, standard deviation.

Journal: Molecular carcinogenesis

Article Title: CD137 Protein Expression Pattern Determines the Functional Role of Galectin-9 in Colorectal Cancer.

doi: 10.1002/mc.23838

Figure Lengend Snippet: FIGURE 8 | Investigating the impacts of Galectin‐9 supplementation and CD137 knockout/overexpression on the infiltration of immune cells on the tumor microenvironment of murine colon cancer. (A) Representative images of CD137 expression distribution in CT26 and MC38 colon cancer tumor tissues, demonstrated through immunohistochemical staining. (B) Comparative analysis of the proportion of CD137‐positive cells in CT26 and MC38 colon cancer tumor tissues. (C) Distribution of activated T cells in CT26 colon cancer tumor tissues, shown using CD3 and CD137 dual immunofluorescence labeling. (D, E) Comparative analysis of the proportion of CD3+ cells and CD3+CD137+ positive cells in CT26 colon cancer tumor tissues. (F) Similarly, using CD3 and CD137 dual immunofluorescence labeling, the distribution of activated T cells in MC38 colon cancer tumor tissues are shown. (G, H) Comparative analysis of the proportion of CD3+ and CD3+CD137+ positive cells in MC38 colon cancer tumor tissues. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle, #p < 0.05 versus Gal‐9, &p < 0.05 versus CD137‐OE, ▲p < 0.05 versus Tnfrsf9‐KO. SD, standard deviation.

Article Snippet: The mice were divided into the following experimental groups: Gal‐9 Group: Mice were given a daily intravenous injection of 30 μg/mouse of Gal‐9 (MedChemExpress, Monmouth Junction, NJ, USA) [22] after tumor cell inoculation.

Techniques: Knock-Out, Over Expression, Expressing, Immunohistochemical staining, Staining, Immunofluorescence, Labeling, Standard Deviation

FIGURE 9 | Effects of Galectin‐9 supplementation and CD137 knockout/overexpression on T cell activation in murine colon cancer tumor tissues. (A) Representative bands of phosphorylated CD3ζ, total CD3ζ, phosphorylated ZAP70, and total ZAP70 protein expression in CT26 tumor tissues were detected using western blot analysis. (B) Quantitative analysis compared the levels of phosphorylated CD3ζ in various groups of CT26 tumor tissues. (C) Quantitative analysis compared the levels of phosphorylated ZAP70 in various groups of CT26 tumor tissues. (D) Representative bands of phosphorylated CD3ζ, total CD3ζ, phosphorylated ZAP70, and total ZAP70 protein expression in MC38 tumor tissues were detected using western blot analysis. (E) Quantitative analysis compared the levels of phosphorylated CD3ζ in various groups of MC38 tumor tissues. (F) Quan- titative analysis compared the levels of phosphorylated ZAP70 in various groups of MC38 tumor tissues. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle, #p < 0.05 versus Gal‐9, &p < 0.05 versus CD137‐OE, ▲p < 0.05 versus Tnfrsf9‐KO. SD, standard deviation.

Journal: Molecular carcinogenesis

Article Title: CD137 Protein Expression Pattern Determines the Functional Role of Galectin-9 in Colorectal Cancer.

doi: 10.1002/mc.23838

Figure Lengend Snippet: FIGURE 9 | Effects of Galectin‐9 supplementation and CD137 knockout/overexpression on T cell activation in murine colon cancer tumor tissues. (A) Representative bands of phosphorylated CD3ζ, total CD3ζ, phosphorylated ZAP70, and total ZAP70 protein expression in CT26 tumor tissues were detected using western blot analysis. (B) Quantitative analysis compared the levels of phosphorylated CD3ζ in various groups of CT26 tumor tissues. (C) Quantitative analysis compared the levels of phosphorylated ZAP70 in various groups of CT26 tumor tissues. (D) Representative bands of phosphorylated CD3ζ, total CD3ζ, phosphorylated ZAP70, and total ZAP70 protein expression in MC38 tumor tissues were detected using western blot analysis. (E) Quantitative analysis compared the levels of phosphorylated CD3ζ in various groups of MC38 tumor tissues. (F) Quan- titative analysis compared the levels of phosphorylated ZAP70 in various groups of MC38 tumor tissues. Data are presented as mean ± SD (n = 6). *p < 0.05 versus vehicle, #p < 0.05 versus Gal‐9, &p < 0.05 versus CD137‐OE, ▲p < 0.05 versus Tnfrsf9‐KO. SD, standard deviation.

Article Snippet: The mice were divided into the following experimental groups: Gal‐9 Group: Mice were given a daily intravenous injection of 30 μg/mouse of Gal‐9 (MedChemExpress, Monmouth Junction, NJ, USA) [22] after tumor cell inoculation.

Techniques: Knock-Out, Over Expression, Activation Assay, Expressing, Western Blot, Standard Deviation

Immunophenotyping panel for multiplexed tissue imaging of cancer.

Journal: Frontiers in Immunology

Article Title: Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging

doi: 10.3389/fimmu.2024.1383932

Figure Lengend Snippet: Immunophenotyping panel for multiplexed tissue imaging of cancer.

Article Snippet: Galectin 9 , REA435 , 50 , 130-124-237 , PE (APC) , Miltenyi Biotec.

Techniques: Imaging